Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
Dórea
José G
JG
Marques
Rejane C
RC
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005035:Ethylmercury Compounds / Q000493:pharmacokinetics / Q000633:toxicity*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008297:Male; D051379:Mice; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects* / Q000493:pharmacokinetics; D018570:Risk Assessment; D013849:Thimerosal / Q000009:adverse effects* / Q000493:pharmacokinetics; D014612:Vaccines / Q000009:adverse effects*
D005035:Ethylmercury Compounds; D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal